Revolution Medicines
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $742 |
Gross Profit | -12,775 | -118,021 | -2,116 |
EBITDA | -154,934 | -139,352 | -158,336 |
EBIT | -156,643 | -140,859 | -161,194 |
Net Income | -133,233 | -116,003 | -161,537 |
Net Change In Cash | 0 | 0 | 742 |
Free Cash Flow | -130,566 | -163,727 | -122,880 |
Cash | 275,713 | 288,432 | 696,148 |
Basic Shares | 165,141 | 164,729 | 141,183 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $11,580 | $35,380 | $29,390 | $42,983 |
Gross Profit | -399,664 | 25,724 | 22,058 | -89,269 |
EBITDA | -430,582 | -239,469 | -179,747 | -101,914 |
EBIT | -439,891 | -249,125 | -187,079 | -108,459 |
Net Income | -436,367 | -248,705 | -179,771 | -108,159 |
Net Change In Cash | 11,580 | 35,380 | 29,390 | 42,983 |
Cost of Revenue | 4,882 | 88,479 | ||
Free Cash Flow | -358,301 | -235,217 | -153,708 | -102,997 |
Cash | 696,148 | 161,412 | 108,497 | 104,268 |
Basic Shares | 113,149 | 80,626 | 72,806 | 66,599 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.94 |
2024-06-30 | -$0.81 |
2024-03-31 | -$0.70 |
2023-12-31 | -$1.14 |
